MedPath

Assessment of Different Protocols for Cervical Dentin Hypersensitivity Treatment

Not Applicable
Completed
Conditions
Dentin Sensitivity
Dentine Hypersensitivity
Hypersensitivity Dentin
Dentin Hypersensitivity
Interventions
Registration Number
NCT02931734
Lead Sponsor
Federal University of Uberlandia
Brief Summary

The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination of dentinal hypersensitivity by the agents Desensibilize KF - FGM Dental Products, Clinpro - 3M Company, Minnesota - USA, Photon Laser III - DMC, Brazil, Desensibilize KF and laser, Desensibilize KF and Clinpro, laser and Clinpro and the association of all products. Data will be collected, tabulated and submitted to statistical analysis.

Detailed Description

Cervical dentin hypersensitivity is a painful condition and is a clinical challenge due to different treatment strategies available. The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination of dentinal hypersensitivity. A hundred forty teeth of healthy patients of both sexes were selected. Visual Analog Scale was used pain (VAS) to measure the intensity of the patient's pain. The teeth will be randomly divided into 7 different groups according to the desensitization treatment under study: Desensibilize KF - FGM Dental Products, Clinpro - 3M Company, Minnesota - USA, Photon Laser III - DMC, Brazil, Desensibilize KF and laser, Desensibilize KF and Clinpro, laser and Clinpro and the association of all products. Data will be collected, tabulated and submitted to statistical analysis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
140
Inclusion Criteria
  • presence of dentin exposure lesions with clinical diagnosis of moderate or severe tooth sensitivity
  • good oral hygiene.
Exclusion Criteria
  • cavities,
  • presence of periodontal disease and or parafunctional habits,
  • cracks or enamel fractures,
  • extensive or unsatisfactory restorations,
  • recent restorations involving the labial surface,
  • dentures,
  • orthodontics.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RMGI, KF, LLLTLow level laser therapyResin modified glass ionomer, potassium nitrate and sodium fluoride 2% and Low level laser therapy - GaAlAs ; an application of the three associated products, every 48 hours; 4 sessions.
Resin modified glass ionomer (RMGI)Resin modified glass ionomerResin modified glass ionomer; an application every 48 hours; 4 sessions.
Low level laser therapy - GaAlAs (LLLT)Low level laser therapyLow level laser therapy - GaAlAs; an application every 48 hours; 4 sessions.
RMGI and KFResin modified glass ionomerResin modified glass ionomer and potassium nitrate and sodium fluoride 2%; an application of the two associated products, every 48 hours; 4 sessions.
RMGI and LLLTResin modified glass ionomerResin modified glass ionomer and Low level laser therapy - GaAlAs; an application of the two associated products, every 48 hours; 4 sessions.
RMGI and LLLTLow level laser therapyResin modified glass ionomer and Low level laser therapy - GaAlAs; an application of the two associated products, every 48 hours; 4 sessions.
KF and LLLTLow level laser therapyPotassium Nitrate and Sodium fluoride 2% and Low level laser therapy - GaAlAs; an application of the two associated products, every 48 hours; 4 sessions.
Potassium Nitrate 2% (KF)Potassium Nitrate 2%Potassium Nitrate and Sodium fluoride 2%; an application every 48 hours; 4 sessions.
RMGI and KFPotassium Nitrate 2%Resin modified glass ionomer and potassium nitrate and sodium fluoride 2%; an application of the two associated products, every 48 hours; 4 sessions.
KF and LLLTPotassium Nitrate 2%Potassium Nitrate and Sodium fluoride 2% and Low level laser therapy - GaAlAs; an application of the two associated products, every 48 hours; 4 sessions.
RMGI, KF, LLLTPotassium Nitrate 2%Resin modified glass ionomer, potassium nitrate and sodium fluoride 2% and Low level laser therapy - GaAlAs ; an application of the three associated products, every 48 hours; 4 sessions.
RMGI, KF, LLLTResin modified glass ionomerResin modified glass ionomer, potassium nitrate and sodium fluoride 2% and Low level laser therapy - GaAlAs ; an application of the three associated products, every 48 hours; 4 sessions.
Primary Outcome Measures
NameTimeMethod
Level of cervical dentin hypersensitivity, measured by visual analog scale24 weeks

Evaluate the reduction in Cervical Dentin Hypersensitivity with a 24 weeks follow up.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Federal University of Uberlandia

🇧🇷

Uberlandia, Minas Gerais, Brazil

© Copyright 2025. All Rights Reserved by MedPath